The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cardiac Marker Market Research Report 2024
Synopsis
The global Cardiac Marker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cardiac Marker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cardiac Marker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cardiac Marker include HyTest, Abbott, Roche Diagnostics, BG Medicine, Biomerieux, Critical Diagnostics, DiaDexus, Response Biomedical and Siemens Healthcare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cardiac Marker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Marker.
Report Scope
The Cardiac Marker market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiac Marker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiac Marker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
HyTest
Abbott
Roche Diagnostics
BG Medicine
Biomerieux
Critical Diagnostics
DiaDexus
Response Biomedical
Siemens Healthcare
Singulex
Thermo Scientific
Trinity Biotech
Sunfory
Lee BioSolutions
Segment by Type
Creatine kinase (CK) MB
Troponin (cTnI and cTnT)
BNP & NT-proBNP
Myogloblin
Others (hs-CRP, D-Dimer, etc.)
Segment by Application
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cardiac Marker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cardiac Marker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Cardiac Marker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cardiac Marker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cardiac Marker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cardiac Marker include HyTest, Abbott, Roche Diagnostics, BG Medicine, Biomerieux, Critical Diagnostics, DiaDexus, Response Biomedical and Siemens Healthcare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cardiac Marker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Marker.
Report Scope
The Cardiac Marker market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiac Marker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiac Marker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
HyTest
Abbott
Roche Diagnostics
BG Medicine
Biomerieux
Critical Diagnostics
DiaDexus
Response Biomedical
Siemens Healthcare
Singulex
Thermo Scientific
Trinity Biotech
Sunfory
Lee BioSolutions
Segment by Type
Creatine kinase (CK) MB
Troponin (cTnI and cTnT)
BNP & NT-proBNP
Myogloblin
Others (hs-CRP, D-Dimer, etc.)
Segment by Application
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cardiac Marker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cardiac Marker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cardiac Marker Market Overview
1.1 Product Overview and Scope of Cardiac Marker
1.2 Cardiac Marker Segment by Type
1.2.1 Global Cardiac Marker Market Value Comparison by Type (2024-2030)
1.2.2 Creatine kinase (CK) MB
1.2.3 Troponin (cTnI and cTnT)
1.2.4 BNP & NT-proBNP
1.2.5 Myogloblin
1.2.6 Others (hs-CRP, D-Dimer, etc.)
1.3 Cardiac Marker Segment by Application
1.3.1 Global Cardiac Marker Market Value by Application: (2024-2030)
1.3.2 Myocardial Infarction
1.3.3 Congestive Heart Failure
1.3.4 Acute Coronary Syndrome
1.3.5 Atherosclerosis
1.3.6 Others
1.4 Global Cardiac Marker Market Size Estimates and Forecasts
1.4.1 Global Cardiac Marker Revenue 2019-2030
1.4.2 Global Cardiac Marker Sales 2019-2030
1.4.3 Global Cardiac Marker Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cardiac Marker Market Competition by Manufacturers
2.1 Global Cardiac Marker Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cardiac Marker Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cardiac Marker Average Price by Manufacturers (2019-2024)
2.4 Global Cardiac Marker Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cardiac Marker, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardiac Marker, Product Type & Application
2.7 Cardiac Marker Market Competitive Situation and Trends
2.7.1 Cardiac Marker Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cardiac Marker Players Market Share by Revenue
2.7.3 Global Cardiac Marker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cardiac Marker Retrospective Market Scenario by Region
3.1 Global Cardiac Marker Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cardiac Marker Global Cardiac Marker Sales by Region: 2019-2030
3.2.1 Global Cardiac Marker Sales by Region: 2019-2024
3.2.2 Global Cardiac Marker Sales by Region: 2025-2030
3.3 Global Cardiac Marker Global Cardiac Marker Revenue by Region: 2019-2030
3.3.1 Global Cardiac Marker Revenue by Region: 2019-2024
3.3.2 Global Cardiac Marker Revenue by Region: 2025-2030
3.4 North America Cardiac Marker Market Facts & Figures by Country
3.4.1 North America Cardiac Marker Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cardiac Marker Sales by Country (2019-2030)
3.4.3 North America Cardiac Marker Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cardiac Marker Market Facts & Figures by Country
3.5.1 Europe Cardiac Marker Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cardiac Marker Sales by Country (2019-2030)
3.5.3 Europe Cardiac Marker Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiac Marker Market Facts & Figures by Country
3.6.1 Asia Pacific Cardiac Marker Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cardiac Marker Sales by Country (2019-2030)
3.6.3 Asia Pacific Cardiac Marker Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cardiac Marker Market Facts & Figures by Country
3.7.1 Latin America Cardiac Marker Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cardiac Marker Sales by Country (2019-2030)
3.7.3 Latin America Cardiac Marker Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardiac Marker Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiac Marker Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cardiac Marker Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cardiac Marker Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cardiac Marker Sales by Type (2019-2030)
4.1.1 Global Cardiac Marker Sales by Type (2019-2024)
4.1.2 Global Cardiac Marker Sales by Type (2025-2030)
4.1.3 Global Cardiac Marker Sales Market Share by Type (2019-2030)
4.2 Global Cardiac Marker Revenue by Type (2019-2030)
4.2.1 Global Cardiac Marker Revenue by Type (2019-2024)
4.2.2 Global Cardiac Marker Revenue by Type (2025-2030)
4.2.3 Global Cardiac Marker Revenue Market Share by Type (2019-2030)
4.3 Global Cardiac Marker Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cardiac Marker Sales by Application (2019-2030)
5.1.1 Global Cardiac Marker Sales by Application (2019-2024)
5.1.2 Global Cardiac Marker Sales by Application (2025-2030)
5.1.3 Global Cardiac Marker Sales Market Share by Application (2019-2030)
5.2 Global Cardiac Marker Revenue by Application (2019-2030)
5.2.1 Global Cardiac Marker Revenue by Application (2019-2024)
5.2.2 Global Cardiac Marker Revenue by Application (2025-2030)
5.2.3 Global Cardiac Marker Revenue Market Share by Application (2019-2030)
5.3 Global Cardiac Marker Price by Application (2019-2030)
6 Key Companies Profiled
6.1 HyTest
6.1.1 HyTest Corporation Information
6.1.2 HyTest Description and Business Overview
6.1.3 HyTest Cardiac Marker Sales, Revenue and Gross Margin (2019-2024)
6.1.4 HyTest Cardiac Marker Product Portfolio
6.1.5 HyTest Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Cardiac Marker Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Cardiac Marker Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Roche Diagnostics
6.3.1 Roche Diagnostics Corporation Information
6.3.2 Roche Diagnostics Description and Business Overview
6.3.3 Roche Diagnostics Cardiac Marker Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Diagnostics Cardiac Marker Product Portfolio
6.3.5 Roche Diagnostics Recent Developments/Updates
6.4 BG Medicine
6.4.1 BG Medicine Corporation Information
6.4.2 BG Medicine Description and Business Overview
6.4.3 BG Medicine Cardiac Marker Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BG Medicine Cardiac Marker Product Portfolio
6.4.5 BG Medicine Recent Developments/Updates
6.5 Biomerieux
6.5.1 Biomerieux Corporation Information
6.5.2 Biomerieux Description and Business Overview
6.5.3 Biomerieux Cardiac Marker Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biomerieux Cardiac Marker Product Portfolio
6.5.5 Biomerieux Recent Developments/Updates
6.6 Critical Diagnostics
6.6.1 Critical Diagnostics Corporation Information
6.6.2 Critical Diagnostics Description and Business Overview
6.6.3 Critical Diagnostics Cardiac Marker Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Critical Diagnostics Cardiac Marker Product Portfolio
6.6.5 Critical Diagnostics Recent Developments/Updates
6.7 DiaDexus
6.6.1 DiaDexus Corporation Information
6.6.2 DiaDexus Description and Business Overview
6.6.3 DiaDexus Cardiac Marker Sales, Revenue and Gross Margin (2019-2024)
6.4.4 DiaDexus Cardiac Marker Product Portfolio
6.7.5 DiaDexus Recent Developments/Updates
6.8 Response Biomedical
6.8.1 Response Biomedical Corporation Information
6.8.2 Response Biomedical Description and Business Overview
6.8.3 Response Biomedical Cardiac Marker Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Response Biomedical Cardiac Marker Product Portfolio
6.8.5 Response Biomedical Recent Developments/Updates
6.9 Siemens Healthcare
6.9.1 Siemens Healthcare Corporation Information
6.9.2 Siemens Healthcare Description and Business Overview
6.9.3 Siemens Healthcare Cardiac Marker Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Siemens Healthcare Cardiac Marker Product Portfolio
6.9.5 Siemens Healthcare Recent Developments/Updates
6.10 Singulex
6.10.1 Singulex Corporation Information
6.10.2 Singulex Description and Business Overview
6.10.3 Singulex Cardiac Marker Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Singulex Cardiac Marker Product Portfolio
6.10.5 Singulex Recent Developments/Updates
6.11 Thermo Scientific
6.11.1 Thermo Scientific Corporation Information
6.11.2 Thermo Scientific Cardiac Marker Description and Business Overview
6.11.3 Thermo Scientific Cardiac Marker Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Thermo Scientific Cardiac Marker Product Portfolio
6.11.5 Thermo Scientific Recent Developments/Updates
6.12 Trinity Biotech
6.12.1 Trinity Biotech Corporation Information
6.12.2 Trinity Biotech Cardiac Marker Description and Business Overview
6.12.3 Trinity Biotech Cardiac Marker Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Trinity Biotech Cardiac Marker Product Portfolio
6.12.5 Trinity Biotech Recent Developments/Updates
6.13 Sunfory
6.13.1 Sunfory Corporation Information
6.13.2 Sunfory Cardiac Marker Description and Business Overview
6.13.3 Sunfory Cardiac Marker Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sunfory Cardiac Marker Product Portfolio
6.13.5 Sunfory Recent Developments/Updates
6.14 Lee BioSolutions
6.14.1 Lee BioSolutions Corporation Information
6.14.2 Lee BioSolutions Cardiac Marker Description and Business Overview
6.14.3 Lee BioSolutions Cardiac Marker Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lee BioSolutions Cardiac Marker Product Portfolio
6.14.5 Lee BioSolutions Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiac Marker Industry Chain Analysis
7.2 Cardiac Marker Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiac Marker Production Mode & Process
7.4 Cardiac Marker Sales and Marketing
7.4.1 Cardiac Marker Sales Channels
7.4.2 Cardiac Marker Distributors
7.5 Cardiac Marker Customers
8 Cardiac Marker Market Dynamics
8.1 Cardiac Marker Industry Trends
8.2 Cardiac Marker Market Drivers
8.3 Cardiac Marker Market Challenges
8.4 Cardiac Marker Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Cardiac Marker Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Cardiac Marker Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Cardiac Marker Market Competitive Situation by Manufacturers in 2023
Table 4. Global Cardiac Marker Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Cardiac Marker Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Cardiac Marker Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Cardiac Marker Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Cardiac Marker Average Price (USD/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Cardiac Marker, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cardiac Marker, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cardiac Marker, Product Type & Application
Table 12. Global Key Manufacturers of Cardiac Marker, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cardiac Marker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Marker as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cardiac Marker Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Cardiac Marker Sales by Region (2019-2024) & (K Doses)
Table 18. Global Cardiac Marker Sales Market Share by Region (2019-2024)
Table 19. Global Cardiac Marker Sales by Region (2025-2030) & (K Doses)
Table 20. Global Cardiac Marker Sales Market Share by Region (2025-2030)
Table 21. Global Cardiac Marker Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Cardiac Marker Revenue Market Share by Region (2019-2024)
Table 23. Global Cardiac Marker Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Cardiac Marker Revenue Market Share by Region (2025-2030)
Table 25. North America Cardiac Marker Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Cardiac Marker Sales by Country (2019-2024) & (K Doses)
Table 27. North America Cardiac Marker Sales by Country (2025-2030) & (K Doses)
Table 28. North America Cardiac Marker Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Cardiac Marker Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Cardiac Marker Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Cardiac Marker Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Cardiac Marker Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Cardiac Marker Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Cardiac Marker Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Cardiac Marker Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Cardiac Marker Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Cardiac Marker Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Cardiac Marker Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Cardiac Marker Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Cardiac Marker Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Cardiac Marker Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Cardiac Marker Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Cardiac Marker Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Cardiac Marker Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Cardiac Marker Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Cardiac Marker Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Cardiac Marker Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Cardiac Marker Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Cardiac Marker Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Cardiac Marker Sales (K Doses) by Type (2019-2024)
Table 51. Global Cardiac Marker Sales (K Doses) by Type (2025-2030)
Table 52. Global Cardiac Marker Sales Market Share by Type (2019-2024)
Table 53. Global Cardiac Marker Sales Market Share by Type (2025-2030)
Table 54. Global Cardiac Marker Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Cardiac Marker Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Cardiac Marker Revenue Market Share by Type (2019-2024)
Table 57. Global Cardiac Marker Revenue Market Share by Type (2025-2030)
Table 58. Global Cardiac Marker Price (USD/Dose) by Type (2019-2024)
Table 59. Global Cardiac Marker Price (USD/Dose) by Type (2025-2030)
Table 60. Global Cardiac Marker Sales (K Doses) by Application (2019-2024)
Table 61. Global Cardiac Marker Sales (K Doses) by Application (2025-2030)
Table 62. Global Cardiac Marker Sales Market Share by Application (2019-2024)
Table 63. Global Cardiac Marker Sales Market Share by Application (2025-2030)
Table 64. Global Cardiac Marker Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Cardiac Marker Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Cardiac Marker Revenue Market Share by Application (2019-2024)
Table 67. Global Cardiac Marker Revenue Market Share by Application (2025-2030)
Table 68. Global Cardiac Marker Price (USD/Dose) by Application (2019-2024)
Table 69. Global Cardiac Marker Price (USD/Dose) by Application (2025-2030)
Table 70. HyTest Corporation Information
Table 71. HyTest Description and Business Overview
Table 72. HyTest Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. HyTest Cardiac Marker Product
Table 74. HyTest Recent Developments/Updates
Table 75. Abbott Corporation Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. Abbott Cardiac Marker Product
Table 79. Abbott Recent Developments/Updates
Table 80. Roche Diagnostics Corporation Information
Table 81. Roche Diagnostics Description and Business Overview
Table 82. Roche Diagnostics Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Roche Diagnostics Cardiac Marker Product
Table 84. Roche Diagnostics Recent Developments/Updates
Table 85. BG Medicine Corporation Information
Table 86. BG Medicine Description and Business Overview
Table 87. BG Medicine Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. BG Medicine Cardiac Marker Product
Table 89. BG Medicine Recent Developments/Updates
Table 90. Biomerieux Corporation Information
Table 91. Biomerieux Description and Business Overview
Table 92. Biomerieux Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. Biomerieux Cardiac Marker Product
Table 94. Biomerieux Recent Developments/Updates
Table 95. Critical Diagnostics Corporation Information
Table 96. Critical Diagnostics Description and Business Overview
Table 97. Critical Diagnostics Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. Critical Diagnostics Cardiac Marker Product
Table 99. Critical Diagnostics Recent Developments/Updates
Table 100. DiaDexus Corporation Information
Table 101. DiaDexus Description and Business Overview
Table 102. DiaDexus Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 103. DiaDexus Cardiac Marker Product
Table 104. DiaDexus Recent Developments/Updates
Table 105. Response Biomedical Corporation Information
Table 106. Response Biomedical Description and Business Overview
Table 107. Response Biomedical Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 108. Response Biomedical Cardiac Marker Product
Table 109. Response Biomedical Recent Developments/Updates
Table 110. Siemens Healthcare Corporation Information
Table 111. Siemens Healthcare Description and Business Overview
Table 112. Siemens Healthcare Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 113. Siemens Healthcare Cardiac Marker Product
Table 114. Siemens Healthcare Recent Developments/Updates
Table 115. Singulex Corporation Information
Table 116. Singulex Description and Business Overview
Table 117. Singulex Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 118. Singulex Cardiac Marker Product
Table 119. Singulex Recent Developments/Updates
Table 120. Thermo Scientific Corporation Information
Table 121. Thermo Scientific Description and Business Overview
Table 122. Thermo Scientific Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 123. Thermo Scientific Cardiac Marker Product
Table 124. Thermo Scientific Recent Developments/Updates
Table 125. Trinity Biotech Corporation Information
Table 126. Trinity Biotech Description and Business Overview
Table 127. Trinity Biotech Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 128. Trinity Biotech Cardiac Marker Product
Table 129. Trinity Biotech Recent Developments/Updates
Table 130. Sunfory Corporation Information
Table 131. Sunfory Description and Business Overview
Table 132. Sunfory Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 133. Sunfory Cardiac Marker Product
Table 134. Sunfory Recent Developments/Updates
Table 135. Lee BioSolutions Corporation Information
Table 136. Lee BioSolutions Description and Business Overview
Table 137. Lee BioSolutions Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 138. Lee BioSolutions Cardiac Marker Product
Table 139. Lee BioSolutions Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Cardiac Marker Distributors List
Table 143. Cardiac Marker Customers List
Table 144. Cardiac Marker Market Trends
Table 145. Cardiac Marker Market Drivers
Table 146. Cardiac Marker Market Challenges
Table 147. Cardiac Marker Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cardiac Marker
Figure 2. Global Cardiac Marker Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Cardiac Marker Market Share by Type in 2023 & 2030
Figure 4. Creatine kinase (CK) MB Product Picture
Figure 5. Troponin (cTnI and cTnT) Product Picture
Figure 6. BNP & NT-proBNP Product Picture
Figure 7. Myogloblin Product Picture
Figure 8. Others (hs-CRP, D-Dimer, etc.) Product Picture
Figure 9. Global Cardiac Marker Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Cardiac Marker Market Share by Application in 2023 & 2030
Figure 11. Myocardial Infarction
Figure 12. Congestive Heart Failure
Figure 13. Acute Coronary Syndrome
Figure 14. Atherosclerosis
Figure 15. Others
Figure 16. Global Cardiac Marker Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Cardiac Marker Market Size (2019-2030) & (US$ Million)
Figure 18. Global Cardiac Marker Sales (2019-2030) & (K Doses)
Figure 19. Global Cardiac Marker Average Price (USD/Dose) & (2019-2030)
Figure 20. Cardiac Marker Report Years Considered
Figure 21. Cardiac Marker Sales Share by Manufacturers in 2023
Figure 22. Global Cardiac Marker Revenue Share by Manufacturers in 2023
Figure 23. The Global 5 and 10 Largest Cardiac Marker Players: Market Share by Revenue in 2023
Figure 24. Cardiac Marker Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 25. Global Cardiac Marker Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Cardiac Marker Sales Market Share by Country (2019-2030)
Figure 27. North America Cardiac Marker Revenue Market Share by Country (2019-2030)
Figure 28. U.S. Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Cardiac Marker Sales Market Share by Country (2019-2030)
Figure 31. Europe Cardiac Marker Revenue Market Share by Country (2019-2030)
Figure 32. Germany Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Cardiac Marker Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Cardiac Marker Revenue Market Share by Region (2019-2030)
Figure 39. China Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Taiwan Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Indonesia Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Thailand Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Malaysia Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Philippines Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Latin America Cardiac Marker Sales Market Share by Country (2019-2030)
Figure 50. Latin America Cardiac Marker Revenue Market Share by Country (2019-2030)
Figure 51. Mexico Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Brazil Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Argentina Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Middle East & Africa Cardiac Marker Sales Market Share by Country (2019-2030)
Figure 55. Middle East & Africa Cardiac Marker Revenue Market Share by Country (2019-2030)
Figure 56. Turkey Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. U.A.E Cardiac Marker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Global Sales Market Share of Cardiac Marker by Type (2019-2030)
Figure 60. Global Revenue Market Share of Cardiac Marker by Type (2019-2030)
Figure 61. Global Cardiac Marker Price (USD/Dose) by Type (2019-2030)
Figure 62. Global Sales Market Share of Cardiac Marker by Application (2019-2030)
Figure 63. Global Revenue Market Share of Cardiac Marker by Application (2019-2030)
Figure 64. Global Cardiac Marker Price (USD/Dose) by Application (2019-2030)
Figure 65. Cardiac Marker Value Chain
Figure 66. Cardiac Marker Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
